Obesity-induced p53 activation in insulin-dependent and independent tissues is inhibited by beta-adrenergic agonist in diet-induced obese rats

Life Sciences
Hamid ZandSama Reza Soltani

Abstract

The purpose of this study was to assay the role of beta-adrenergic receptor signaling in the regulation of obesity-induced p53 in high fat feeding obese rats. The role of beta-adrenergic receptor/cyclic AMP in the regulation of p53 and its downstream mediators was evaluated by western blot and real-time quantitative RT-PCR among diet induced rats. Beta-adrenergic receptor agonist, isoproterenol, and an adenylate cyclase activator, forskolin, at a single dose significantly reduced insulin resistance consistent with a decrease in total and phospho-p53 levels in insulin and non-insulin metabolic target tissues. The decrease of p53 signaling was consistent with the elevation of AKT and subsequent activation. Obese rats exposed to fasting also exhibited improvement in insulin action despite a slight effect on p53 level. Results of the present study obviously showed that beta-adrenergic receptor agonist/cAMP prevented obesity-induced p53 activation. Although this effect in metabolic insulin target tissues tempted us to consider them as insulin sensitizers in obesity-related diabetes, p53 inhibition in non-insulin target tissues warned about the impairment of anti-cancer mechanisms in obese subjects.

References

Jan 15, 2002·The Journal of Clinical Endocrinology and Metabolism·Jirí HrebícekLudek Cízek
May 8, 2003·The Journal of Biological Chemistry·Naoya YahagiNobuhiro Yamada
Apr 27, 2004·Revue D'épidémiologie Et De Santé Publique·M AlgaziM G Lê
Sep 8, 2006·Trends in Endocrinology and Metabolism : TEM·Andrew G RenehanAllan Flyvbjerg
Apr 11, 2008·Nature Reviews. Molecular Cell Biology·Adilson GuilhermeMichael P Czech
May 16, 2009·Current Hypertension Reports·Alexandre A da SilvaJohn E Hall
Sep 1, 2009·Nature Medicine·Tohru MinaminoIssei Komuro
Dec 22, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven W Cole, Anil K Sood
Sep 7, 2012·Cold Spring Harbor Perspectives in Biology·Brian A Hemmings, David F Restuccia
Feb 2, 2013·Current Medical Research and Opinion·Matteo MonamiEdoardo Mannucci
Mar 8, 2014·Cell Biology International·Jyothi Kumari PosaB S Lakshmi
Aug 19, 2014·Lancet·Peter T Campbell
Oct 10, 2014·International Journal of Applied & Basic Medical Research·Kanwal Mohinder Dev Singh PanagGitanjali Goyal

❮ Previous
Next ❯

Citations

Dec 21, 2016·SpringerPlus·Elham EhrampoushSeyed Amin Kouhpayeh
Feb 15, 2017·Oxidative Medicine and Cellular Longevity·Justyna StrycharzAgnieszka Sliwinska
Sep 6, 2018·International Journal of Molecular Sciences·Jelena KrsticAndreas Prokesch
Oct 12, 2018·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Durgesh KumarAnil N Gaikwad
Mar 21, 2018·Scientific Reports·Alireza GhaemiReza Homayounfar
Jul 1, 2020·Endocrine Regulations·Alireza AskariReza Alipoor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.